Items where Author is "Wiegand, A"
Group by: Item Type | No Grouping Jump to: Article Number of items: 4. ArticleMcKinnon, JE and Mailliard, RB and Swindells, S and Wilkin, TJ and Borowski, LA and Roper, JM and Bastow, B and Kearney, M and Wiegand, A and Mellors, JW and Rinaldo, CR (2014) Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201). PLoS ONE, 9 (5). Kearney, MF and Spindler, J and Wiegand, A and Shao, W and Anderson, EM and Maldarelli, F and Ruscetti, FW and Mellors, JW and Hughes, SH and Le Grice, SFJ and Coffin, JM (2012) Multiple sources of contamination in samples from patients reported to have XMRV infection. PLoS ONE, 7 (2). Gandhi, RT and Zheng, L and Bosch, RJ and Chan, ES and Margolis, DM and Read, S and Kallungal, B and Palmer, S and Medvik, K and Lederman, MM and Alatrakchi, N and Jacobson, JM and Wiegand, A and Kearney, M and Coffin, JM and Mellors, JW and Eron, JJ (2010) The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: A randomized controlled trial. PLoS Medicine, 7 (8). ISSN 1549-1277 Maldarelli, F and Palmer, S and King, MS and Wiegand, A and Polis, MA and Mican, JA and Kovacs, JA and Davey, RT and Rock-Kress, D and Dewar, R and Liu, S and Metcalf, JA and Rehm, C and Brun, SC and Hanna, GJ and Kempf, DJ and Coffin, JM and Mellors, JW (2007) ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia. PLoS Pathogens, 3 (4). 484 - 488. ISSN 1553-7366 |